This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Dawei Li: Innovator in Pharmaceutical Chemistry
Introduction
Dawei Li is a prominent inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with potential therapeutic applications.
Latest Patents
Dawei Li holds a patent for "Furo[3,2-g]chromene compounds and uses thereof." This patent discloses furo[3,2-g]chromene derivatives represented by a specific formula, including stereoisomers, pharmaceutically acceptable salts, and pharmaceutical compositions. These compounds are noted for their uses as estrogen receptor modulators, highlighting their potential in medical applications.
Career Highlights
Li is affiliated with Shenyang Pharmaceutical University, where he engages in research and development in the pharmaceutical sciences. His work focuses on innovative solutions that address various health challenges through chemical compounds.
Collaborations
Dawei Li collaborates with notable colleagues, including Shihui Wang and Erfang Huang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Dawei Li's contributions to pharmaceutical chemistry, particularly through his patented innovations, underscore his role as a key figure in advancing medical science. His work continues to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile